Prev Arrow Stocks

Humana Inc. ($HUM) Stock Forecast: Down 2.8% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Humana Inc.?

Humana Inc. (NYSE: HUM) is a leading health insurance company in the United States, offering a wide range of healthcare services to its customers. The stock had a strong bearish movement today amidst recent developments in the market.

Why is Humana Inc. going down?

HUM stock is down 2.8% on Jul 3, 2024 14:36

  • Walmart exploring the sale of closed health clinics, including discussions with Humana, might have raised concerns about potential losses or liabilities associated with the clinics, impacting Humana's stock negatively.
  • The class action lawsuits filed against Humana by various law firms could have created uncertainty and legal risks for the company, leading to a decrease in investor confidence and a bearish market movement.
  • Investors being reminded to secure counsel before an important deadline in a securities class action against Humana could have added pressure on the stock as legal issues often weigh on the company's financial outlook.
  • The ongoing investigations and claims by different law firms against Humana might have contributed to the negative sentiment surrounding the stock, resulting in the bearish market movement observed today.

HUM Price Chart

HUM News

Walmart Explores Sale Of Closed Health Clinics To Recoup Investments: Report

Walmart Inc. (NYSE: WMT ) has reportedly entered discussions with prospective buyers to offload its recently closed medical clinics. In April, Walmart announced the shutdown of all 51 of its health clinics and terminated its virtual healthcare services, citing the unsustainable nature of the business model. The retail giant is now exploring options to recover some of its investments in the clinics, engaging in conversations with various entities, including health insurance company Humana Inc. (NYSE: HUM ), reported Reuters. Walmart has expressed its aim … Full story available on Benzinga.com

https://www.benzinga.com/markets/equities/24/07/39613518/walmart-explores-sale-of-closed-health-clinics-to-recoup-investments-report

News Article Image Walmart Explores Sale Of Closed Health Clinics To Recoup Investments: Report

ROSEN, A LEADING LAW FIRM, Encourages Humana Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUM - Humana ( NYSE:HUM )

NEW YORK, July 01, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Humana Inc. HUM between July 27, 2022 and January 24, 2024, both dates inclusive ( the "Class Period" ) , of the important August 2, 2024 lead plaintiff ...

https://www.benzinga.com/pressreleases/24/07/g39586845/rosen-a-leading-law-firm-encourages-humana-inc-investors-to-secure-counsel-before-important-deadli

News Article Image ROSEN, A LEADING LAW FIRM, Encourages Humana Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUM - Humana  ( NYSE:HUM )

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hertz, Humana, Fat Brands, and Scotts and Encourages Investors to Contact the Firm - FAT Brands ( NASDAQ:FAT ) , Hertz Global Holdings ( NASDAQ:HTZ )

NEW YORK, June 30, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Hertz Global Holdings, Inc. HTZ, Humana Inc. HUM, FAT Brands Inc.

https://www.benzinga.com/pressreleases/24/06/g39566499/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-hertz

News Article Image Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hertz, Humana, Fat Brands, and Scotts and Encourages Investors to Contact the Firm - FAT Brands  ( NASDAQ:FAT ) , Hertz Global Holdings  ( NASDAQ:HTZ )

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humana Inc. - HUM - Humana ( NYSE:HUM )

NEW YORK, June 30, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. ( "Humana" or the "Company" ) HUM. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ( or 888.4-POMLAW ) , toll-free, ...

https://www.benzinga.com/pressreleases/24/06/g39565800/shareholder-alert-pomerantz-law-firm-announces-the-filing-of-a-class-action-against-humana-inc-hum

News Article Image SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humana Inc. - HUM - Humana  ( NYSE:HUM )

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humana

Faruqi Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Humana To Contact Him Directly To Discuss Their…

https://markets.businessinsider.com/news/stocks/shareholder-notice-faruqi-faruqi-llp-investigates-claims-on-behalf-of-investors-of-humana-1033463102

News Article Image SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humana

Humana Inc. Price History

28.05.2024 - HUM Stock was up 6.5%

  • The bullish movement in Humana Inc. (HUM) stock could be attributed to the positive collaboration news with PsychArmor for better veteran care, showcasing the company's commitment to enhancing healthcare services.
  • The upcoming release of the second quarter 2024 financial results on July 31, 2024, might have generated investor optimism and anticipation for strong performance.
  • Despite facing a lawsuit for securities law violations, investors seem to be focusing more on the company's strategic partnerships and upcoming financial results, leading to the bullish market movement.

30.04.2024 - HUM Stock was up 3.6%

  • Humana (HUM) stock experienced a strong bullish movement today, possibly driven by positive market sentiment and investor confidence in the company's performance.
  • The news about UnitedHealth Group flagging Medicaid enrollment issues and the subsequent fall in health insurer shares may have initially caused some uncertainty in the healthcare sector, including Humana. However, the resilience shown by Humana amidst industry challenges could have reassured investors, leading to the bullish movement.
  • The options market activity around Humana (HUM) stock suggests that investors are closely monitoring the company's movements and potential opportunities, indicating a heightened interest in its future performance.
  • Despite the challenges faced by the healthcare industry, Humana's strategic positioning and financial stability, as indicated by its recent earnings report, may have contributed to the stock's positive momentum and overall bullish movement today.

29.04.2024 - HUM Stock was down 0.9%

  • Humana's stock experienced a bearish movement today, likely influenced by negative sentiment in the health insurance industry, which emerged after UnitedHealth Group's mention of Medicaid enrollment issues.
  • Concerns were raised among investors due to UnitedHealth's statement regarding challenges with Medicaid reimbursement rates stemming from ongoing enrollment problems. This led to a sell-off not just in UnitedHealth shares but also in other health insurers like Humana.
  • Despite the positive impact that the partnership between Humana Group and Google Cloud to enhance IT security in healthcare may have in the long term, immediate worries regarding Medicaid enrollment concerns are currently outweighing any positive developments.
  • The market's response to Humana's stock today highlights investors' cautious attitude towards the health insurance sector, given the uncertainties surrounding Medicaid reimbursement rates and enrollment obstacles.

29.04.2024 - HUM Stock was down 5.1%

  • Humana (HUM) saw a decline in its stock price today despite a recent partnership with Google Cloud aimed at enhancing IT security within care services.
  • Investors may have reacted negatively to Humana's potential partnership with a private equity firm to expand Oak Street Health, which could lead to increased competition and ownership dilution.
  • Uncertainty surrounding Humana's earnings forecasts following its most recent financial report likely impacted investor sentiment.
  • Although Artisan Value Fund included Humana (HUM) in its portfolio and the overall positive trend in US equity markets, the stock's performance today appears to be influenced by these factors.

02.03.2024 - HUM Stock was down 12.4%

  • Humana (HUM) stock plummeted by 13.8% due to the unexpected decision not to increase Medicare Advantage rates for 2025, leading to increased costs for health insurance companies.
  • The market reacted negatively to the news as health insurance stocks are facing rising costs amidst inflation, interest rate hikes, and higher medical prices.
  • The breakdown of merger discussions between major players in the health insurance space also contributed to the bearish sentiment surrounding Humana and other health insurance stocks.

02.03.2024 - HUM Stock was down 13.7%

  • Humana's stock dropped by 13.8% due to the announcement of unchanged Medicare Advantage rates for 2025, raising concerns about increased costs for the company.
  • The unexpected decision by the Biden Administration on Medicare Advantage rates had a negative impact on health insurance stocks like Humana.
  • Market instability, driven by factors such as rising bond yields, increasing oil prices, and geopolitical tensions, worsened the bearish trend in Humana's stock as investors sought safer investments.
  • Despite the stock being oversold and potentially undervalued, the lack of anticipated rate increases led to intense selling pressure, underscoring the susceptibility of health insurance stocks to regulatory changes and market conditions.

02.03.2024 - HUM Stock was down 11.7%

  • The bearish movement in Humana's stock could be attributed to the disappointment in the Medicare Advantage rate rise, which fell short of expectations, leading to a negative investor sentiment.
  • The overall market sentiment was also influenced by the surge in bond yields to 4.36% and the rise in oil prices to a new five-month high, causing concerns about potential Fed rate cuts in June.
  • The oversold nature of health care stocks, including Humana, may have contributed to profit-taking activities, further pressuring the stock price downwards.
  • With the geopolitical fear premium over the Israel-Iran conflict and the strength in the commodities complex, investors might have shifted their focus away from health insurance stocks like Humana towards other sectors perceived as more lucrative in the current market conditions.

05.02.2024 - HUM Stock was down 1.8%

  • Today, Humana Inc. (HUM) experienced a strong bearish movement for the following reasons:
  • The company confirmed its earnings forecast in upcoming investor meetings, which may have failed to meet market expectations, leading to a negative reaction from investors.
  • Increased costs have been a challenge for Humana, impacting its profitability and causing a bearish sentiment among shareholders.
  • Comparisons questioning the value proposition of Humana compared to its competitors like Cigna (CI) may have raised concerns about the company's growth prospects.
  • Despite the overall market rising, Humana's stock price slid, indicating specific company-related factors contributing to the bearish movement.

27.01.2024 - HUM Stock was up 1.5%

  • The collaboration with Veda to improve provider directories suggests that Humana is focusing on enhancing its services and customer experience, which could attract more clients and drive up its stock price.
  • This strategic partnership may lead to increased operational efficiency and cost savings for Humana, positively impacting its bottom line and investor confidence.
  • The market's bullish reaction to this news indicates that investors view this collaboration as a positive development for Humana's long-term growth prospects, leading to increased buying interest in the stock.

26.00.2024 - HUM Stock was down 11.7%

  • The bearish movement in Humana's stock today can be attributed to the following factors:
  • 1. Disappointing financial results: Humana reported a fourth-quarter FY23 adjusted loss per share, missing the consensus estimate. This negative earnings report likely contributed to the decline in the stock price.
  • 2. Lowered guidance: The company also issued 2024 guidance that fell short of expectations, indicating potential challenges ahead. This announcement may have further dampened investor sentiment and led to the bearish movement.
  • 3. Concerns about rising medical costs and regulations: Humana's warning about higher medical costs and government regulations impacting its results through 2025 may have raised concerns among investors. These factors could potentially impact the company's profitability and growth prospects, leading to a sell-off in the stock.
  • 4. Overall market sentiment: The broader market sentiment and trends in the healthcare sector may have also influenced the bearish movement in Humana's stock. Negative sentiment towards healthcare stocks or a broader market downturn could have contributed to the decline.
  • In summary, Humana's bearish movement today can be attributed to disappointing financial results, lowered guidance, concerns about rising costs and regulations, and overall market sentiment.

19.00.2024 - HUM Stock was down 7.8%

  • The bearish movement in HUM stock today could be attributed to the following factors:
  • 1. Health care cost warning: Humana's stock plunged after a major health care cost warning. This suggests that the company may be facing challenges in managing medical costs, which could impact its profitability.
  • 2. Rising inpatient treatment costs: Humana's Q4 warning on rising inpatient treatment costs also contributed to the bearish movement. This indicates that the company may be experiencing higher expenses related to inpatient care, which could affect its financial performance.
  • 3. Medicare Advantage concerns: The risks associated with Medicare Advantage, in which Humana has made significant investments, are coming into focus. The program's rising utilization rates are putting pressure on insurance companies like Humana, potentially impacting their stocks.
  • 4. Market conditions: The overall market movement, with mixed performance in the major U.S. equity indexes, may have also influenced HUM stock. Market sentiment and investor behavior can play a role in the stock's movement.
  • In summary, Humana's bearish movement today can be attributed to concerns about health care costs, rising inpatient treatment expenses, Medicare Advantage risks, and broader market conditions.

29.10.2023 - HUM Stock was down 5.6%

  • Humana Inc and Cigna Group are reportedly discussing a merger deal, which could create a new powerhouse in the health insurance industry. This news might have caused uncertainty and concern among investors, leading to a bearish movement in HUM stock.
  • The potential merger deal between Humana and Cigna could have raised questions about the future prospects and competitiveness of Humana as a standalone company, resulting in a negative sentiment among investors.
  • The uncertainty surrounding the merger negotiations and the potential impact on Humana's business strategy and financials might have led investors to sell off their HUM shares, contributing to the bearish movement.
  • The market reaction to the news suggests that investors are cautious and are closely monitoring the developments of the merger talks, as it could have significant implications for the healthcare insurance industry.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.